{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:41:23Z","timestamp":1792428083010,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":117,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fundacion Le Cado"},{"name":"Instituto de Salud Carlos III","award":["PI22\/00969"],"award-info":[{"award-number":["PI22\/00969"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"DOI":"10.1186\/s13058-026-02330-8","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T07:05:24Z","timestamp":1782284724000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breastfeeding shapes a unique tumor-immune landscape in pregnancy-associated breast cancer from GEICAM-EMBARCAM study"],"prefix":"10.1186","volume":"28","author":[{"given":"Regina","family":"Pe\u00f1a-Enr\u00edquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Guerrero-Zotano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"D\u00edaz-Chacon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda Jerez","family":"Gilarranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose J. Ponce","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Miguel","family":"Cejalvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Santaballa","family":"Bertran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Galve-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Fern\u00e1ndez","family":"Aramburo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca Cantos S\u00e1nchez","family":"de Ibarg\u00fcen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Anton-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Helena","family":"Lopez-Ceballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"De La Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eva","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Blancas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Vidal-Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ruiz-Borrego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Jim\u00e9nez-Arranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ponferrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Bautista-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mart\u00ednez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"L\u00f3pez-Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Rivas-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Rinc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosal\u00eda","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Guil-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"de la Haba-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2330_CR1","doi-asserted-by":"publisher","unstructured":"Siegel Mph RL, Giaquinto AN, Ahmedin |, Dvm J, Siegel RL. Cancer statistics, 2024. CA Cancer J Clin 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/CAAC.21820.","DOI":"10.3322\/CAAC.21820"},{"key":"2330_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/AOG.0B013E3181B19154","volume":"114","author":"TML Andersson","year":"2009","unstructured":"Andersson TML, Johansson ALV, Hsieh CC, Cnattingius S, Lambe M. Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009;114:568\u201372. https:\/\/doi.org\/10.1097\/AOG.0B013E3181B19154.","journal-title":"Obstet Gynecol"},{"key":"2330_CR3","doi-asserted-by":"publisher","unstructured":"Boere I, Lok C, Poortmans P, Koppert L, Painter R, vd Heuvel-Eibrink MM, et al. Breast cancer during pregnancy: epidemiology, phenotypes, presentation during pregnancy and therapeutic modalities. Best Pract Res Clin Obstet Gynaecol 2022;82 46\u201359. https:\/\/doi.org\/10.1016\/J.BPOBGYN.2022.05.001.","DOI":"10.1016\/J.BPOBGYN.2022.05.001"},{"key":"2330_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S1470-2045(21)00183-2","volume":"22","author":"F Amant","year":"2021","unstructured":"Amant F, Lefr\u00e8re H, Borges VF, Cardonick E, Lambertini M, Loibl S, et al. The definition of pregnancy-associated breast cancer is outdated and should no longer be used. Lancet Oncol. 2021;22:753. https:\/\/doi.org\/10.1016\/S1470-2045(21)00183-2.","journal-title":"Lancet Oncol"},{"key":"2330_CR5","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1158\/1055-9965.EPI-11-0515","volume":"20","author":"ALV Johansson","year":"2011","unstructured":"Johansson ALV, Andersson TML, Hsieh CC, Cnattingius S, Lambe M. Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum. Cancer Epidemiol Biomark Prev. 2011;20:1865\u201372. https:\/\/doi.org\/10.1158\/1055-9965.EPI-11-0515.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"2330_CR6","doi-asserted-by":"publisher","unstructured":"Allouch S, Gupta I, Malik S, Al Farsi HF, Vranic S, Al Moustafa AE. Breast cancer during pregnancy: a marked propensity to triple-negative phenotype. Front Oncol 2020 10. https:\/\/doi.org\/10.3389\/FONC.2020.580345.","DOI":"10.3389\/FONC.2020.580345"},{"key":"2330_CR7","unstructured":"De la Haba J, M\u00ednguez P, Rojo F, Mart\u00edn M, Alba E, Servitja S, et al. Gestational breast cancer: distinctive molecular and clinio-epidemiological features. J Mammary Gland Biol Neoplasia 2024."},{"key":"2330_CR8","doi-asserted-by":"publisher","unstructured":"Pe\u00f1a-Enr\u00edquez R, Bermejo B, Poll\u00e1n M, D\u00edaz-Chac\u00f3n A, Gilarranz YJ, Ponce Lorenzo JJ, et al. Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study. Npj Breast Cancer 2025 11:1 2025;11:1\u201316. https:\/\/doi.org\/10.1038\/s41523-025-00718-x.","DOI":"10.1038\/s41523-025-00718-x"},{"key":"2330_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13040604","author":"G Tsipouras","year":"2023","unstructured":"Tsipouras G, Galati F, Magri V, Arias-Cadena PA, Moffa G, Rizzo V, et al. Pregnancy-associated breast cancer: a diagnostic and therapeutic. Challenge. 2023. https:\/\/doi.org\/10.3390\/diagnostics13040604.","journal-title":"Challenge"},{"key":"2330_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/CAC2.12316","volume":"42","author":"X Chen","year":"2022","unstructured":"Chen X, Song E. The theory of tumor ecosystem. Cancer Commun. 2022;42:587. https:\/\/doi.org\/10.1002\/CAC2.12316.","journal-title":"Cancer Commun"},{"key":"2330_CR11","doi-asserted-by":"publisher","unstructured":"Schedin P. Pregnancy-associated breast cancer and metastasis. Nature Reviews Cancer 2006 6:4 2006;6:281\u201391. https:\/\/doi.org\/10.1038\/nrc1839.","DOI":"10.1038\/nrc1839"},{"key":"2330_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/IJGC-2020-002072","volume":"31","author":"H Lefr\u00e8re","year":"2021","unstructured":"Lefr\u00e8re H, Lenaerts L, Borges VF, Schedin P, Neven P, Amant F. Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation. Inter J Gynecologic Cancer. 2021;31:412\u201322. https:\/\/doi.org\/10.1136\/IJGC-2020-002072.","journal-title":"Inter J Gynecologic Cancer"},{"key":"2330_CR13","doi-asserted-by":"publisher","unstructured":"Russo IH, Russo J. Pregnancy-Induced Changes in Breast Cancer Risk n.d. https:\/\/doi.org\/10.1007\/s10911-011-9228-y.","DOI":"10.1007\/s10911-011-9228-y"},{"key":"2330_CR14","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1002\/IJC.29181","volume":"136","author":"HA Martinson","year":"2015","unstructured":"Martinson HA, Jindal S, Durand-Rougely C, Borges VF, Schedin P. Wound healing-like immune program facilitates postpartum mammary gland involution and tumor progression. Inter J Cancer J Inter Du Cancer. 2015;136:1803. https:\/\/doi.org\/10.1002\/IJC.29181.","journal-title":"Inter J Cancer J Inter Du Cancer"},{"key":"2330_CR15","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1038\/BJC.2014.434","volume":"111","author":"A Castell\u00f3","year":"2014","unstructured":"Castell\u00f3 A, Poll\u00e1n M, Buijsse B, Ruiz A, Casas AM, Baena-Ca\u00f1ada JM, et al. Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study. Br J Cancer. 2014;111:1454\u201362. https:\/\/doi.org\/10.1038\/BJC.2014.434.","journal-title":"Br J Cancer"},{"key":"2330_CR16","doi-asserted-by":"publisher","unstructured":"Lope V, Guerrero-Zotano \u00c1, Fern\u00e1ndez de Larrea-Baz N, Antol\u00edn S, Benavent Vi\u00f1uales M, Bermejo B, et al. Cross-sectional and longitudinal associations of adherence to WCRF\/AICR cancer prevention recommendations with health-related quality of life in breast cancer survivors. Health-EpiGEICAM study. J Nutr Health Aging 2024;28 100312. https:\/\/doi.org\/10.1016\/J.JNHA.2024.100312.","DOI":"10.1016\/J.JNHA.2024.100312"},{"key":"2330_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"PS Bernard","year":"2009","unstructured":"Bernard PS, Parker JS, Mullins M, Cheung MCU, Leung S, Voduc D, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160. https:\/\/doi.org\/10.1200\/JCO.2008.18.1370.","journal-title":"J Clin Oncol"},{"key":"2330_CR18","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"2330_CR19","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/NAR\/GKY1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et al. STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607. https:\/\/doi.org\/10.1093\/NAR\/GKY1131.","journal-title":"Nucleic Acids Res"},{"key":"2330_CR20","doi-asserted-by":"publisher","unstructured":"Menyhart O, Kothalawala WJ, Gy\u0151rffy B. A gene set enrichment analysis for the cancer hallmarks. J Pharm Anal 2024:101065. https:\/\/doi.org\/10.1016\/J.JPHA.2024.101065.","DOI":"10.1016\/J.JPHA.2024.101065"},{"key":"2330_CR21","doi-asserted-by":"publisher","unstructured":"Bartha \u00c1, Gy\u0151rffy B. TNMplot.com: A web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci 2021 22:1\u201312. https:\/\/doi.org\/10.3390\/IJMS22052622.","DOI":"10.3390\/IJMS22052622"},{"key":"2330_CR22","doi-asserted-by":"publisher","unstructured":"L\u00e1nczky A, Gy\u0151rffy B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation. J Med Internet Res 2021;23. https:\/\/doi.org\/10.2196\/27633.","DOI":"10.2196\/27633"},{"key":"2330_CR23","doi-asserted-by":"publisher","unstructured":"Tolaney SM, Garrett-Mayer E, White J, Blinder VS, Foster JC, Amiri-Kordestani L, et al. Updated standardized definitions for efficacy end points (STEEP) in adjuvant breast cancer clinical trials: STEEP Version 2.0. J Clinical Oncol 2021;39:2720\u201331. https:\/\/doi.org\/10.1200\/JCO.20.03613\/SUPPL_FILE\/DS_JCO.20.03613.PDF.","DOI":"10.1200\/JCO.20.03613\/SUPPL_FILE\/DS_JCO.20.03613.PDF"},{"key":"2330_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154413","volume":"244","author":"EM Proussaloglou","year":"2023","unstructured":"Proussaloglou EM, Blanco LZ, Siziopikou KP. Updates in the pathology of pregnancy associated breast cancer (PABC). Pathology-Res Practice. 2023;244:154413. https:\/\/doi.org\/10.1016\/j.prp.2023.154413.","journal-title":"Pathology-Res Practice"},{"key":"2330_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1470-2045(17)30891-4","volume":"19","author":"ER Copson","year":"2018","unstructured":"Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, et al. Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study. Lancet Oncol. 2018;19:169\u201380. https:\/\/doi.org\/10.1016\/S1470-2045(17)30891-4.","journal-title":"Lancet Oncol"},{"key":"2330_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2021.721797\/BIBTEX","volume":"11","author":"F Wu","year":"2021","unstructured":"Wu F, Sun Y, Chen J, Li H, Yao K, Liu Y, et al. The Oncogenic role of APC\/C activator protein Cdc20 by an integrated pan-cancer analysis in human tumors. Front Oncol. 2021;11:721797. https:\/\/doi.org\/10.3389\/FONC.2021.721797\/BIBTEX.","journal-title":"Front Oncol"},{"key":"2330_CR27","doi-asserted-by":"publisher","unstructured":"Gao T, Han Y, Yu L, Ao S, Li Z, Ji A. CCNA2 is a prognostic biomarker for ER+ breast cancer and tamoxifen resistance. PLoS One 2014 9. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0091771,.","DOI":"10.1371\/JOURNAL.PONE.0091771"},{"key":"2330_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12957-021-02301-7\/FIGURES\/7","volume":"19","author":"J Kim","year":"2021","unstructured":"Kim J. In silico analysis of differentially expressed genesets in metastatic breast cancer identifies potential prognostic biomarkers. World J Surg Oncol. 2021;19:1\u201315. https:\/\/doi.org\/10.1186\/S12957-021-02301-7\/FIGURES\/7.","journal-title":"World J Surg Oncol"},{"key":"2330_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJCA.2026.116230","volume":"235","author":"A Spata","year":"2026","unstructured":"Spata A, Ribeiro JM, Vigneri P, Zambelli A, Zeghondy J, Bousrih C, et al. Comprehensive review of pregnancy associated breast cancer: clinical features, molecular characteristics and novel therapies. Eur J Cancer. 2026;235:116230. https:\/\/doi.org\/10.1016\/J.EJCA.2026.116230.","journal-title":"Eur J Cancer"},{"key":"2330_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-024-54963-4","volume":"14","author":"C Hove","year":"2024","unstructured":"Hove C, Chua KJ, Martin MA, Hubble M, Boddy AM. Variation in maternal lactation practices associated with changes in diurnal maternal inflammation. Sci Rep. 2024;14:1\u201310.","journal-title":"Sci Rep"},{"key":"2330_CR31","doi-asserted-by":"publisher","unstructured":"Wallace TR, Tarullo SE, Crump LS, Lyons TR. Studies of postpartum mammary gland involution reveal novel pro-metastatic mechanisms. J Cancer Metastasis Treat 2019 5. https:\/\/doi.org\/10.20517\/2394-4722.2019.01.","DOI":"10.20517\/2394-4722.2019.01"},{"key":"2330_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17418-7","volume":"7","author":"HW Hyatt","year":"2017","unstructured":"Hyatt HW, Zhang Y, Hood WR, Kavazis AN. Lactation has persistent effects on a mother\u2019s metabolism and mitochondrial function. Sci Rep. 2017;7:1\u201313.","journal-title":"Sci Rep"},{"key":"2330_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/S10911-024-09568-Y","volume":"29","author":"R Vickers","year":"2024","unstructured":"Vickers R, Porter W. Immune cell contribution to mammary gland development. J Mammary Gland Biol Neoplasia. 2024;29:16. https:\/\/doi.org\/10.1007\/S10911-024-09568-Y.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2330_CR34","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/AJHB.22351","volume":"25","author":"CW Kuzawa","year":"2013","unstructured":"Kuzawa CW, Adair LS, Borja J, McDade TW. C-reactive protein by pregnancy and lactational status among Filipino young adult women. Am J Hum Biol. 2013;25:131\u20134. https:\/\/doi.org\/10.1002\/AJHB.22351.","journal-title":"Am J Hum Biol"},{"key":"2330_CR35","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3945\/AN.114.007377","volume":"6","author":"F Hassiotou","year":"2015","unstructured":"Hassiotou F, Geddes DT. Immune cell-mediated protection of the mammary gland and the infant during breastfeeding. Adv Nutr. 2015;6:267\u201375. https:\/\/doi.org\/10.3945\/AN.114.007377.","journal-title":"Adv Nutr"},{"key":"2330_CR36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/S13058-019-1163-7\/FIGURES\/8","volume":"21","author":"MM Basree","year":"2019","unstructured":"Basree MM, Shinde N, Koivisto C, Cuitino M, Kladney R, Zhang J, et al. Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer. Breast Cancer Res. 2019;21:80. https:\/\/doi.org\/10.1186\/S13058-019-1163-7\/FIGURES\/8.","journal-title":"Breast Cancer Res"},{"key":"2330_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13058-024-01933-3","volume":"27","author":"S Majumder","year":"2025","unstructured":"Majumder S, Mishra S, Shinde N, Cuitino MC, Bauer M, Ahirwar D, et al. Divergent paths of mammary gland involution: unveiling the cellular dynamics in abruptly and gradually involuted mouse models. Breast Cancer Res. 2025;27:1. https:\/\/doi.org\/10.1186\/S13058-024-01933-3.","journal-title":"Breast Cancer Res"},{"key":"2330_CR38","doi-asserted-by":"publisher","unstructured":"Takabatake Y, Oxvig C, Nagi C, Adelson K, Jaffer S, Schmidt H, et al. Lactation opposes pappalysin-1-driven pregnancy-associated breast cancer. EMBO Mol Med 2016;8 388\u2013406. https:\/\/doi.org\/10.15252\/EMMM.201606273.","DOI":"10.15252\/EMMM.201606273"},{"key":"2330_CR39","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.1158\/0008-5472.CAN-20-3143","volume":"81","author":"Q Guo","year":"2021","unstructured":"Guo Q, Bartish M, Gon\u00e7alves C, Huang F, Smith-Voudouris J, Krisna SS, et al. The MNK1\/2\u2013eIF4E axis supports immune suppression and metastasis in postpartum breast cancer. Cancer Res. 2021;81:3876\u201389.","journal-title":"Cancer Res"},{"key":"2330_CR40","doi-asserted-by":"publisher","first-page":"6852","DOI":"10.1158\/1538-7445.AM2024-6852","volume":"84","author":"I-C Chen","year":"2024","unstructured":"Chen I-C, Chen C-H, Hsu C-L, Lu T-P, Lu Y-S, Lin C-H. Abstract 6852: Immune microenvironment profiling of pregnancy associated breast cancer: a transcriptomic and multiplex immunohistochemical analyses. Cancer Res. 2024;84:6852\u20136852. https:\/\/doi.org\/10.1158\/1538-7445.AM2024-6852.","journal-title":"Cancer Res"},{"key":"2330_CR41","doi-asserted-by":"publisher","unstructured":"Jindal S, Pennock ND, Sun D, Horton W, Ozaki MK, Narasimhan J, et al. Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nat Commun 2021;12. https:\/\/doi.org\/10.1038\/S41467-021-26505-3.","DOI":"10.1038\/S41467-021-26505-3"},{"key":"2330_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41586-025-09713-5","volume":"2025","author":"B Virassamy","year":"2025","unstructured":"Virassamy B, Caramia F, Savas P, Harris MA, Pan J-W, Wang J, et al. Parity and lactation induce T cell mediated breast cancer protection. Nature. 2025;2025:1\u20133. https:\/\/doi.org\/10.1038\/S41586-025-09713-5.","journal-title":"Nature"},{"key":"2330_CR43","doi-asserted-by":"publisher","unstructured":"Zhang Q, Bi J, Zheng X, Chen Y, Wang H, Wu W, et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nature Immunology 2018 19:7 2018 19:723\u201332. https:\/\/doi.org\/10.1038\/s41590-018-0132-0.","DOI":"10.1038\/s41590-018-0132-0"},{"key":"2330_CR44","first-page":"374","volume":"2021","author":"L Zheng","year":"1979","unstructured":"Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Sci. 1979;2021:374.","journal-title":"Sci"},{"key":"2330_CR45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/CAC2.12539","volume":"44","author":"GR Khosravi","year":"2024","unstructured":"Khosravi GR, Mostafavi S, Bastan S, Ebrahimi N, Gharibvand RS, Eskandari N. Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Commun. 2024;44:521\u201353. https:\/\/doi.org\/10.1002\/CAC2.12539.","journal-title":"Cancer Commun"},{"key":"2330_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.982986","volume":"13","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Ke S, Chen J, Qin Z, Zhang W, Yuan Y, et al. FOXP3+ regulatory T cells and the immune escape in solid tumours. Front Immunol. 2022;13:982986. https:\/\/doi.org\/10.3389\/FIMMU.2022.982986.","journal-title":"Front Immunol"},{"key":"2330_CR47","doi-asserted-by":"publisher","first-page":"734","DOI":"10.4049\/JIMMUNOL.1800023","volume":"201","author":"CB Betts","year":"2018","unstructured":"Betts CB, Pennock ND, Caruso BP, Ruffell B, Borges VF, Schedin P. Mucosal immunity in the female murine mammary gland. J Immunol. 2018;201:734\u201346. https:\/\/doi.org\/10.4049\/JIMMUNOL.1800023.","journal-title":"J Immunol"},{"key":"2330_CR48","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1038\/S41590-023-01578-Y","volume":"24","author":"MW Rudloff","year":"2023","unstructured":"Rudloff MW, Zumbo P, Favret NR, Roetman JJ, Detr\u00e9s Rom\u00e1n CR, Erwin MM, et al. Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division. Nat Immunol. 2023;24:1527. https:\/\/doi.org\/10.1038\/S41590-023-01578-Y.","journal-title":"Nat Immunol"},{"key":"2330_CR49","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/S1470-2045(19)30026-9","volume":"20","author":"FJ Esteva","year":"2019","unstructured":"Esteva FJ, Hubbard-Lucey VM, Tang J, Pusztai L. Immunotherapy and targeted therapy combinations in metastatic breast cancer. Lancet Oncol. 2019;20:e175\u201386. https:\/\/doi.org\/10.1016\/S1470-2045(19)30026-9.","journal-title":"Lancet Oncol"},{"key":"2330_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/2159-8290.CD-22-0475","volume":"13","author":"SS Onkar","year":"2023","unstructured":"Onkar SS, Carleton NM, Lucas PC, Bruno TC, Lee AV, Vignali DAA, et al. The great immune escape: understanding the divergent immune response in breast cancer subtypes. Cancer Discov. 2023;13:23. https:\/\/doi.org\/10.1158\/2159-8290.CD-22-0475.","journal-title":"Cancer Discov"},{"key":"2330_CR51","doi-asserted-by":"publisher","first-page":"14185","DOI":"10.1007\/S00432-023-05194-Z","volume":"149","author":"H Dou","year":"2023","unstructured":"Dou H, Jia S, Ba Y, Luo D, Yu P, Li F, et al. Clinical characteristics and pathologic complete response (pCR) rate after neoadjuvant chemotherapy in postpartum women with breast cancer. J Cancer Res Clin Oncol. 2023;149:14185\u2013204. https:\/\/doi.org\/10.1007\/S00432-023-05194-Z.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02330-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02330-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02330-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:02:07Z","timestamp":1792425727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02330-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2330"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02330-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9169157\/v1","asserted-by":"object"}]},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the applicable Clinical Research Ethics Committees of the participating Spanish hospitals. This observational study is registered at ClinicalTrials.gov (NCT04603820) on 20 October 2020. The study was carried out in compliance with the ethical guidelines of the Declaration of Helsinki (October 2013) and good clinical practice guidelines. Written informed consent was obtained from each participant prior to clinical and biological data collection.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.G.-Z. declares speaker\u2019s honoraria from Eli Lilly, Menarini, Novartis, and Pfizer; travel support to attend medical conferences from Gilead, Novartis, Pfizer, and Roche; and consulting\/advisory role fees from Eli Lilly, Exact Sciences, and Roche. B.B. declares consulting\/advisory role fees from AstraZeneca, Eli Lilly, Gilead, Menarini, MSD, Pfizer, and Roche; speakers\u2019 honoraria from AstraZeneca, Daiichi Sankyo, Eli Lilly, Gilead, MSD, Novartis, and Roche; and travel support to attend medical conferences from Daiichi Sankyo, Gilead, and Pfizer. YJG declares speaker's honoraria from Roche, Novartis, Pfizer, AstraZeneca and Daichii Sankyo; and travel grants from AstraZeneca, Novartis, Pfizer, Daichii Sankyo and Gilead. FM declares consulting\/advisory role with Novartis, Pfizer, AstraZeneca, MSD, Daiichi Sankyo and Seagen; speakers' bureau from Pfizer and Novartis; research funding from Pfizer; travel\/accommodations expenses by Pfizer, Novartis and Gilead. IB declares having research funding from Agendia, AstraZeneca, Lilly, Pfizer and Roche; honoraria as medical monitor from Medical Scientia Innovation Research (MEDSIR); honoraria and advisor collaboration from AstraZeneca, Bristol-Myers Squibb, Celgene, Daiichi-Sankyo, Eisai, Gilead, Gr\u00fcnenthal, GSK, Jazz Pharmaceutical, Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen and Veracyte; travel and meeting attendance grants from AstraZeneca, Bristol-Myers Squibb, Daiichi-Sankyo, Gilead, Lilly, Novartis, Pfizer, Pierre-Fabre and Roche. MM declares research grants from Novartis, Puma Biotechnology, and Roche outside the submitted work; consulting\/advisory fees from Amgen, AstraZeneca, Daiichi Sankyo, Eli Lilly, Novartis, Pfizer, PharmaMar, Puma Biotechnology, Roche\/Genentech, and Taiho Oncology; and spearkers\u2019 honoraria from Amgen, AstraZeneca, Daiichi Sankyo, Genentech\/Roche, Novartis, and Pfizer. All remaining authors have declared no competing Interest.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"178"}}